Our Bond Faces Triple Nasdaq Delisting Notices — 180 Days to Regain Compliance
OBAI sits 44% above its 52-week low of $0.432.
Summary
Our Bond received three Nasdaq non‑compliance notices on July 14, 2026 — for the bid price, public float value, and total market value of listed securities. The company has 180 days to regain compliance or face delisting.
Key Events · Legal and Risk Events · OBAI
-
Triple Nasdaq Non‑Compliance Notices
On July 14, 2026, Nasdaq notified Our Bond that it fails three continued listing standards: (1) minimum bid price of $1.00 (stock at $0.62), (2) minimum market value of publicly held shares of $15 million, and (3) minimum market value of listed securities of $50 million.
-
180‑Day Cure Period Until January 11, 2027
The company has until January 11, 2027, to regain compliance with all three requirements. Compliance is achieved by meeting each standard for at least 10 consecutive business days during that window.
-
Delisting Risk Compounds Going‑Concern Pressures
The delisting notices arrive against a backdrop of widening losses, high‑cost debt, and a going‑concern warning disclosed in the May 2026 10‑Q. A move to the OTC would further impair liquidity and access to capital.
-
No Immediate Trading Suspension
The notices do not immediately affect the company's Nasdaq listing. Our Bond will appear on Nasdaq's non‑compliant list starting five business days after the notice date.
Analysis · OBAI · Technology
Nasdaq flagged Our Bond for three listing violations: the stock has traded below $1 for 30 days, and both the public float and total market value of listed securities have fallen below required minimums. The company has until January 11, 2027, to fix all three — a tall order for a micro‑cap already burning cash and warning about its ability to continue as a going concern. If it fails, a move to the OTC would likely shrink liquidity further and make raising capital even harder.
At the time of this filing, OBAI was trading at $0.62 on NASDAQ in the Technology sector, with a market capitalization of approximately $15.2M. The 52-week trading range was $0.43 to $38.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.